Friday, December 19, 2025
ADVT 
International

Gorbachev's death could prove a point of yet more tension between Russia and West

Darpan News Desk IANS, 31 Aug, 2022 11:44 AM
  • Gorbachev's death could prove a point of yet more tension between Russia and West

London, Aug 31 (IANS) The death of Mikhail Gorbachev could prove a point of yet more tension between Russia and the West as it emerged on Wednesday the former Soviet leader may not receive a state funeral, media reports said.

Gorbachev died on Tuesday at the age of 91 in the midst of the war in Ukraine which resulted in a complete breakdown in relations between Vladimir Putin and Western leaders, who have implemented strict sanctions designed to hamper the Kremlin's war effort, Daily Mail reported.

When the first President of Russia - Boris Yeltsin - died in 2007, ex-US Presidents George Bush senior and Bill Clinton both flew to Moscow alongside former British premier John Major.

And when Gorbachev's predecessor in the Kremlin, Konstantin Chernenko, died in 1985, a clutch of serving Western leaders, including British PM Margaret Thatcher and West German Chancellor Helmut Kohl attended his funeral, Daily Mail reported.

But Putin's spokesman Dmitry Peskov announced on Wednesday that Kremlin was still deciding on the scale of the funeral for Gorbachev, who was despised by many pro-Putin hardliners for his role in bringing about the end of the Soviet Union.

And the sorry state of political relations combined with the wide ranging sanctions placed on Russia by Western governments mean Putin is unlikely to allow political leaders from Europe and the US to attend any ceremony, Daily Mail reported.

With sanctions imposed by the West on Russia, including a ban on flights to Moscow, the Russian tyrant is highly unlikely to agree to host Western leaders who have for months openly criticised him and his actions.

Putin may also be reluctant to come into close proximity with Western leaders at a time when rumours of his declining health are rife and his public appearances are rare and often painstakingly choreographed.

Photo courtesy of IANS. 

MORE International ARTICLES

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided

With Trump sick, all eyes on Wednesday's VP debate

With Trump sick, all eyes on Wednesday's VP debate
Questions persist about Donald Trump's health following his COVID-19 diagnosis, as well as the age of 77-year-old challenger Joe Biden.

With Trump sick, all eyes on Wednesday's VP debate

Magnitsky sanctions demanded in Iranian shootdown

Magnitsky sanctions demanded in Iranian shootdown
There were 176 people killed when the Iranian military shot down Ukraine International Airlines Flight PS752 on Jan. 8, shortly after it took off from Tehran.

Magnitsky sanctions demanded in Iranian shootdown

Berry scare: U.S. eyeing foreign produce imports

Berry scare: U.S. eyeing foreign produce imports
U.S. Trade Representative Robert Lighthizer served notice last week that the Trump administration fears domestic producers are being unfairly harmed by what they call a recent increase in berry imports from Canada and Mexico.

Berry scare: U.S. eyeing foreign produce imports

EU regulator starts safety review of coronavirus drug

EU regulator starts safety review of coronavirus drug
In a statement on Friday, the EU regulator said it isn’t clear whether remdesivir was causing the “acute kidney injury,” but that the issue “warrants further investigation.”

EU regulator starts safety review of coronavirus drug